News
New! CCC Publication in Current Oncology
We are pleased to announce the publication of our manuscript, "Understanding Colorectal Cancer Patient Experiences with Family Practitioners in Canada,"...
The Survivorship Experience
What is survivorship? Survivorship is a term used to describe people living with Cancer, in treatment for Cancer, who have...
Phase II study to assess QBECO SSI Efficacy in the Treatment of Colorectal Cancer That Has Spread to the Liver (PERIOP-06)
PERIOP-06 is a phase II study that will assess the efficacy of a medicinal product known as a Site Specific...
Gut microbiome signature identified in KRAS-mutated colorectal cancer patients
May 2024 According to a recent study published in Microbiology Spectrum, specific microbiome “signatures” were associated with KRAS mutations in...
Can Spending Time in Nature Help with Cancer and Treatment Symptoms and Side-Effects?
While treatment may be lifesaving, many folks experience a wide variety of treatment side-effects that lead to a reduction in...
Ongoing clinical trial: phase 3 study of perioperative dostarlimab in participants with untreated T4N0 or stage III dMMR/MSI-H resectable colon cancer (AZUR-2)
This study aims to investigate dostarlimab therapy in patients with locally advanced mismatch-repair deficient (dMMR) / microsatellite instability high (MSI-H) rectal cancer who have not received any previous treatment. Patients who achieve a complete clinical response (no detectable tumour remains)...
Get social
New! CCC Publication in Current Oncology
We are pleased to announce the publication of our manuscript, "Understanding Colorectal Cancer Patient Experiences with Family Practitioners in Canada,"...
The Survivorship Experience
What is survivorship? Survivorship is a term used to describe people living with Cancer, in treatment for Cancer, who have...
Phase II study to assess QBECO SSI Efficacy in the Treatment of Colorectal Cancer That Has Spread to the Liver (PERIOP-06)
PERIOP-06 is a phase II study that will assess the efficacy of a medicinal product known as a Site Specific...
Gut microbiome signature identified in KRAS-mutated colorectal cancer patients
May 2024 According to a recent study published in Microbiology Spectrum, specific microbiome “signatures” were associated with KRAS mutations in...
Can Spending Time in Nature Help with Cancer and Treatment Symptoms and Side-Effects?
While treatment may be lifesaving, many folks experience a wide variety of treatment side-effects that lead to a reduction in...
Ongoing clinical trial: phase 3 study of perioperative dostarlimab in participants with untreated T4N0 or stage III dMMR/MSI-H resectable colon cancer (AZUR-2)
This study aims to investigate dostarlimab therapy in patients with locally advanced mismatch-repair deficient (dMMR) / microsatellite instability high (MSI-H) rectal cancer who have not received any previous treatment. Patients who achieve a complete clinical response (no detectable tumour remains)...
